Treace Medical Concepts (TMCI) Assets Average (2021 - 2026)
Treace Medical Concepts' (TMCI) quarterly Assets Average came in at $182.6 million in Q2 2026, down 11.43% on a YoY basis from $206.1 million in Q2 2025, and down 2.54% quarter-over-quarter from $187.3 million in Q1 2026.
Analysis
Treace Medical Concepts (TMCI) Assets Average (2021 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Assets Average for 6 consecutive years, with $182.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 11.43% year-over-year to $182.6 million; the trailing twelve-month figure through Jun 2026 stood at $182.6 million (down 11.43% YoY), and the FY2025 full-year result was $203.8 million, down 13.08% from the prior year.
- Assets Average slipped to $182.6 million in Q2 2026 per TMCI's latest filing, from $187.3 million in the prior quarter.
- Across five years, Assets Average topped out at $249.4 million in Q2 2023 and bottomed at $143.7 million in Q1 2022.
- Historically, Assets Average has averaged $203.1 million across 5 years, with a median of $205.1 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Assets Average soared 262.84% in 2022, then decreased 14.49% in 2025.
- Over 5 years, Assets Average stood at $157.7 million in 2022, then jumped by 56.04% to $246.1 million in 2023, then decreased by 12.65% to $215.0 million in 2024, then decreased by 9.96% to $193.6 million in 2025, then fell by 5.69% to $182.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $182.6 million, $187.3 million, and $193.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | 182.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182.58 Mn |
| Mar 31, 2026 | 187.34 Mn |
| Dec 31, 2025 | 193.59 Mn |
| Sep 30, 2025 | 201.52 Mn |
| Jun 30, 2025 | 206.14 Mn |
| Mar 31, 2025 | 211.47 Mn |
| Dec 31, 2024 | 215.01 Mn |
| Sep 30, 2024 | 219.50 Mn |
| Jun 30, 2024 | 234.40 Mn |
| Mar 31, 2024 | 247.32 Mn |
| Dec 31, 2023 | 246.13 Mn |
| Sep 30, 2023 | 245.00 Mn |
| Jun 30, 2023 | 249.41 Mn |
| Mar 31, 2023 | 204.10 Mn |
| Dec 31, 2022 | 157.73 Mn |
| Sep 30, 2022 | 157.58 Mn |
| Jun 30, 2022 | 152.62 Mn |
| Mar 31, 2022 | 143.67 Mn |
| Dec 31, 2021 | 139.21 Mn |
| Sep 30, 2021 | 139.94 Mn |